Princeton, NJ – February 6th, 2023

KYBORA is pleased to announce that Khai Meng Ang has joined its team as Senior Advisor. In this capacity, he will be responsible for expanding KYBORA’s operations in China (Shanghai). Khai brings 35 years of experience in the pharmaceuticals and medtech industries across Asia and in the US. He started his career in finance with Eli Lilly and subsequently assumed general manager positions in Malaysia, China and Southeast Asia; since 2007 he has been based in Shanghai as China and Regional General Manager for Medtronic, UCB, Hospira and Roche Diabetes Care. In these positions he established or grew businesses significantly by driving strategic investment and business development; as GM he also possesses significant experience in full commercial value chain from regulatory excellence to customer focus. Currently he serves as a Board member at listed and private companies.

“I am thrilled to have Khai join KYBORA,” said Alan Vanderborght, CEO of KYBORA. “His deep knowledge of the Chinese market and his relationships with decision makers in the industry will help us grow rapidly in the region.”


About the author.


20 years of experience in international business development in the pharmaceutical industry. Head of commercial operations and business development for Bristol-Myers Squibb in 16 Latin American countries. Global management consultant. Speaks French and Spanish fluently. Completed nine transactions in global markets in the past three years.

No Comments. Leave a comment  

Leave a Reply

Your email address will not be published. Required fields are marked *